Lista de obras - Bruce Russell - Dominio Público Uruguay

A Spiking Neural Network Methodology and System for Learning and Comparative Analysis of EEG Data From Healthy Versus Addiction Treated Versus Addiction Not Treated Subjects.

artículo científico publicado en 2015

A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress.

artículo científico publicado en 2013

Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study

artículo científico publicado en 2015

Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.

artículo científico publicado en 2015

Auditory event-related potentials in methadone substituted opiate users.

artículo científico publicado en 2015

Carbohydrate Reward and Psychosis: An Explanation For Neuroleptic Induced Weight Gain and Path to Improved Mental Health? ⬇️

artículo científico publicado el 1 de junio de 2011

Changes in resting EEG following methadone treatment in opiate addicts

artículo científico publicado en 2014

Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

artículo científico publicado en 2011

Determining the subjective and physiological effects of BZP on human females

artículo científico publicado en 2009

Determining the subjective effects of TFMPP in human males.

artículo científico publicado en 2010

Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).

artículo científico publicado en 2013

Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?

artículo científico publicado en 2015

Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication

artículo científico publicado en 2010

Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2013

Extensive gray matter volume reduction in treatment-resistant schizophrenia.

artículo científico publicado en 2015

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia

artículo científico publicado en 2015

Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers.

artículo científico publicado en 2015

Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.

artículo científico publicado en 2016

Legal piperazine-containing party pills--a new trend in substance misuse

artículo científico publicado en 2007

Metabolic interactions with piperazine-based 'party pill' drugs

artículo científico publicado en 2009

Methadone maintenance treatment and cognitive function: a systematic review

artículo científico publicado en 2013

Neuropsychological performance of methadone-maintained opiate users.

artículo científico publicado en 2014

New Zealand to establish fit for purpose regulation for new psychoactive substances.

artículo científico publicado en 2012

Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants

artículo científico publicado en 2009

Pharmacotherapy for treatment-resistant schizophrenia ⬇️

artículo científico publicado el 17 de marzo de 2011

Prevalence of cognitive enhancer use among New Zealand tertiary students.

artículo científico publicado en 2015

Quantitative EEG and Low-Resolution Electromagnetic Tomography (LORETA) Imaging of Patients Undergoing Methadone Treatment for Opiate Addiction

artículo científico publicado en 2015

Reply to Sumnall (2013), 'The New Zealand new psychoactive substances regime--a step in the right direction, but questions still remain'.

artículo científico publicado en 2013

Resting EEG and ERPs findings in methadone-substituted opiate users: a review.

artículo científico

Stimulus properties of some analogues of 4-methylaminorex

artículo científico publicado en 1995

Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination

scientific article published on 28 April 2011

The new psychoactive substances regime in New Zealand: a different approach to regulation

article

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

artículo científico publicado en 2016

Using fMRI to compare the effects of benzylpiperazine with dexamphetamine - Their differences during the Stroop paradigm

artículo científico publicado en 2016

Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans

artículo científico publicado en 2010

Varenicline improves motor and cognitive symptoms in early Huntington's disease

artículo científico publicado en 2016

Lista de obras de Bruce Russell

A Spiking Neural Network Methodology and System for Learning and Comparative Analysis of EEG Data From Healthy Versus Addiction Treated Versus Addiction Not Treated Subjects.

A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress.

Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study

Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.

Auditory event-related potentials in methadone substituted opiate users.

Carbohydrate Reward and Psychosis: An Explanation For Neuroleptic Induced Weight Gain and Path to Improved Mental Health? ⬇️

Changes in resting EEG following methadone treatment in opiate addicts

Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

Determining the subjective and physiological effects of BZP on human females

Determining the subjective effects of TFMPP in human males.

Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).

Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?

Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication

Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Extensive gray matter volume reduction in treatment-resistant schizophrenia.

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia

Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers.

Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.

Legal piperazine-containing party pills--a new trend in substance misuse

Metabolic interactions with piperazine-based 'party pill' drugs

Methadone maintenance treatment and cognitive function: a systematic review

Neuropsychological performance of methadone-maintained opiate users.

New Zealand to establish fit for purpose regulation for new psychoactive substances.

Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants

Pharmacotherapy for treatment-resistant schizophrenia ⬇️

Prevalence of cognitive enhancer use among New Zealand tertiary students.

Quantitative EEG and Low-Resolution Electromagnetic Tomography (LORETA) Imaging of Patients Undergoing Methadone Treatment for Opiate Addiction

Reply to Sumnall (2013), 'The New Zealand new psychoactive substances regime--a step in the right direction, but questions still remain'.

Resting EEG and ERPs findings in methadone-substituted opiate users: a review.

Stimulus properties of some analogues of 4-methylaminorex

Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination

The new psychoactive substances regime in New Zealand: a different approach to regulation

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Using fMRI to compare the effects of benzylpiperazine with dexamphetamine - Their differences during the Stroop paradigm

Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans

Varenicline improves motor and cognitive symptoms in early Huntington's disease